SG11201501465SA - Method for screening cancer - Google Patents

Method for screening cancer

Info

Publication number
SG11201501465SA
SG11201501465SA SG11201501465SA SG11201501465SA SG11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA
Authority
SG
Singapore
Prior art keywords
screening cancer
cancer
screening
Prior art date
Application number
SG11201501465SA
Inventor
Hungcheng Lai
Original Assignee
Nat Defense Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Defense Medical Ct filed Critical Nat Defense Medical Ct
Publication of SG11201501465SA publication Critical patent/SG11201501465SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
SG11201501465SA 2012-08-31 2012-08-31 Method for screening cancer SG11201501465SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/001211 WO2014032205A1 (en) 2012-08-31 2012-08-31 Method for screening cancer

Publications (1)

Publication Number Publication Date
SG11201501465SA true SG11201501465SA (en) 2015-05-28

Family

ID=50182336

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501465SA SG11201501465SA (en) 2012-08-31 2012-08-31 Method for screening cancer

Country Status (15)

Country Link
US (2) US10221458B2 (en)
EP (1) EP2891720B1 (en)
JP (1) JP2015526096A (en)
KR (1) KR20150067151A (en)
CN (1) CN105579590A (en)
AU (1) AU2012388616A1 (en)
BR (1) BR112015004423A8 (en)
CA (1) CA2883671A1 (en)
HU (1) HUE049697T2 (en)
IL (1) IL237436A0 (en)
MX (1) MX2015002637A (en)
PH (1) PH12015500430A1 (en)
RU (1) RU2700088C2 (en)
SG (1) SG11201501465SA (en)
WO (1) WO2014032205A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2891720B1 (en) 2012-08-31 2020-04-08 National Defense Medical Center Method for screening cancer
US20170321247A1 (en) * 2014-08-18 2017-11-09 Wako Pure Chemical Industries, Ltd. Cancer marker and cancer determination method
WO2016060278A1 (en) * 2014-10-17 2016-04-21 国立大学法人東北大学 Method for estimating sensitivity to drug therapy for colorectal cancer
JP6655243B2 (en) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 Method for detecting oral precancerous lesions
WO2017067477A1 (en) * 2015-10-20 2017-04-27 Hung-Cheng Lai Methods for making diagnosis and/or prognosis of gynecologic neoplasm
WO2018008153A1 (en) * 2016-07-08 2018-01-11 有限会社ハヌマット Method for determining possibility of onset of colon cancer
GB201703406D0 (en) * 2017-03-02 2017-04-19 Ucl Business Plc Diagnostic and prognostic methods
CN109234378A (en) * 2018-09-27 2019-01-18 中国航天员科研训练中心 Predict the method and DNA methylation marker of weightless bone loss osteocalcin OC downside risk
EP3950954A4 (en) * 2018-12-05 2022-08-24 Keio University Method for determining prognosis of endometrial cancer
US20230357852A1 (en) * 2020-08-19 2023-11-09 Mayo Foundation For Medical Education And Research Detecting non-hodgkin lymphoma
CN114540489B (en) * 2020-11-27 2024-01-30 广州达健生物科技有限公司 Cervical cancer early screening detection kit and application thereof
CN113337614A (en) * 2021-08-05 2021-09-03 北京起源聚禾生物科技有限公司 Marker, primer probe and kit for early screening and diagnosis of endometrial cancer
EP4130297A1 (en) * 2021-08-05 2023-02-08 Beijing OriginPoly Bio-Tec Co., Ltd. Markers, primers, probes and kit for early screening and diagnosis of endometrial cancer

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10112515B4 (en) * 2001-03-09 2004-02-12 Epigenomics Ag Method for the detection of cytosine methylation patterns with high sensitivity
US7461163B2 (en) 2002-08-16 2008-12-02 Infrastructure Innovations Llc Real time mesh measurement system stream latency and jitter measurements
US20100273151A1 (en) 2004-05-28 2010-10-28 Fred Hutchinson Cancer Research Center Genome-wide analysis of palindrome formation and dna methylation
US7749702B2 (en) * 2005-04-15 2010-07-06 Epigenomics Ag Methods and nucleic acids for the analyses of cellular proliferative disorders
GB0700374D0 (en) * 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
TW200831900A (en) 2007-01-23 2008-08-01 Hong-Zheng Lai Cancer screen method
EP2118319A4 (en) * 2007-02-12 2010-08-04 Univ Johns Hopkins Early detection and prognosis of colon cancers
US7820386B2 (en) 2007-06-15 2010-10-26 National Defense Medical Center Cancer screening method
JP2009005621A (en) * 2007-06-28 2009-01-15 Fujifilm Corp Detection method including malignancy of neuroblastoma and control method
WO2009105549A2 (en) 2008-02-19 2009-08-27 Oncomethylome Sciences Sa Detection and prognosis of lung cancer
US9850540B2 (en) * 2008-03-14 2017-12-26 Genomictree, Inc. Method for detecting lung cancer using lung cancer-specific methylation marker gene
EP2626435B1 (en) 2008-03-21 2016-06-01 MDxHealth S.A. Detection and prognosis of cervical cancer
CN101570779B (en) * 2008-04-29 2016-02-17 赖鸿政 A kind of method of cancer screening
US9670546B2 (en) * 2008-07-15 2017-06-06 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
TWI385252B (en) 2009-04-16 2013-02-11 Nat Defense Medical Ct Cancer screening method
RU2405837C1 (en) * 2009-07-06 2010-12-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Early dna-diagnostic technique of prostate cancer
US8048634B2 (en) 2009-08-18 2011-11-01 National Defense Medical Center Cancer screening method
JP2011160711A (en) 2010-02-09 2011-08-25 Keio Gijuku Method for using frequency of methylation of specific gene as biomarker for gynecologic cancer
US20110301050A1 (en) * 2010-03-22 2011-12-08 Pfeifer Gerd P Dna hypermethylation brain cancer markers
TWI408235B (en) * 2010-06-03 2013-09-11 Univ China Medical Gene marker and method for detection of oral cancer
JP5693895B2 (en) * 2010-08-26 2015-04-01 公益財団法人ヒューマンサイエンス振興財団 Cervical cancer test marker and cervical cancer test method
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
CN103703173A (en) * 2011-02-02 2014-04-02 精密科学公司 Digital sequence analysis of dna methylation
GB201102014D0 (en) * 2011-02-04 2011-03-23 Ucl Business Plc Method for predicting risk of developing cancer
US20130041047A1 (en) 2011-06-01 2013-02-14 Aros Applied Biotechnology As Urinary Methylation Markers for Bladder Cancer
US20130022974A1 (en) 2011-06-17 2013-01-24 The Regents Of The University Of Michigan Dna methylation profiles in cancer
EP2751288A4 (en) 2011-08-30 2015-09-30 Nat Defense Medical Ct Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers
EP2891720B1 (en) 2012-08-31 2020-04-08 National Defense Medical Center Method for screening cancer

Also Published As

Publication number Publication date
WO2014032205A1 (en) 2014-03-06
MX2015002637A (en) 2015-11-23
BR112015004423A2 (en) 2017-08-08
CA2883671A1 (en) 2014-03-06
RU2700088C2 (en) 2019-09-12
US10221458B2 (en) 2019-03-05
EP2891720B1 (en) 2020-04-08
BR112015004423A8 (en) 2019-01-29
IL237436A0 (en) 2015-04-30
EP2891720A4 (en) 2016-11-09
HUE049697T2 (en) 2020-10-28
AU2012388616A1 (en) 2015-04-02
JP2015526096A (en) 2015-09-10
US20150361502A1 (en) 2015-12-17
KR20150067151A (en) 2015-06-17
CN105579590A (en) 2016-05-11
PH12015500430A1 (en) 2015-04-20
US20190136330A1 (en) 2019-05-09
EP2891720A1 (en) 2015-07-08
RU2015111627A (en) 2016-10-20

Similar Documents

Publication Publication Date Title
IL239262A0 (en) Methods for screening
ZA201501833B (en) Method for obtaining 1-kestone
IL237436A0 (en) Method for screening cancer
HK1208709A1 (en) A method of screening for colorectal cancer
GB201212937D0 (en) Method
GB201212932D0 (en) Method
PT2876447T (en) Method for detecting cancer
GB201213636D0 (en) Method
GB201212934D0 (en) Method
GB201210858D0 (en) Method
PL2876446T3 (en) Method for detecting cancer
EP2837619A4 (en) Method for producing beta -alkoxypropionamide
GB201120317D0 (en) Screening method
EP2824130A4 (en) Method for producing polydialkylsilane
EP2758778A4 (en) Screening method
EP2880048A4 (en) Method
EP2894477A4 (en) Method for determining breast cancer
GB201202198D0 (en) Method
SG11201501567QA (en) Method for producing 7-octenal
GB201211393D0 (en) Method
GB201213770D0 (en) Screening methods
GB201214029D0 (en) method
GB201210147D0 (en) Method
IL234526A (en) Method for producing dithiine tetracarboximides
GB201213858D0 (en) Method